HEADER CYTOKINE 29-NOV-00 1GA3 TITLE NMR STRUCTURE OF INTERLEUKIN-13 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-13; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IL-13, IL13; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL13, NC30; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMAL-IL-13 KEYWDS CYTOKINE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR E.Z.EISENMESSER,D.A.HORITA,A.S.ALTIERI,R.A.BYRD REVDAT 4 26-FEB-20 1GA3 1 COMPND SOURCE KEYWDS REMARK REVDAT 4 2 1 DBREF SEQADV HELIX SHEET REVDAT 4 3 1 ATOM REVDAT 3 25-DEC-19 1GA3 1 REMARK SEQADV REVDAT 2 24-FEB-09 1GA3 1 VERSN REVDAT 1 04-JUL-01 1GA3 0 JRNL AUTH E.Z.EISENMESSER,D.A.HORITA,A.S.ALTIERI,R.A.BYRD JRNL TITL SOLUTION STRUCTURE OF INTERLEUKIN-13 AND INSIGHTS INTO JRNL TITL 2 RECEPTOR ENGAGEMENT JRNL REF J.MOL.BIOL. V. 310 231 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11419949 JRNL DOI 10.1006/JMBI.2001.4765 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.Z.EISENMESSER,D.A.HORITA,R.A.BYRD REMARK 1 TITL SECONDARY STRUCTURE AND BACKBONE RESONANCE ASSIGNMENTS FOR REMARK 1 TITL 2 HUMAN INTERLEUKIN-13 REMARK 1 REF J.BIOMOL.NMR V. 19 93 2001 REMARK 1 REFN ISSN 0925-2738 REMARK 1 DOI 10.1023/A:1008336103603 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.Z.EISENMESSER,R.B.KAPUST,J.P.NAWROCKI,D.S.WAUGH,R.A.BYRD, REMARK 1 AUTH 2 M.J.MAZZULLA,L.K.PANNELL REMARK 1 TITL EXPRESSION, PURIFICATION, REFOLDING, AND CHARACTERIZATION OF REMARK 1 TITL 2 RECOMBINANT HUMAN INTERLEUKIN-13: UTILIZATION OF REMARK 1 TITL 3 INTRACELLULAR PROCESSING REMARK 1 REF PROTEIN EXPR.PURIF. V. 20 186 2000 REMARK 1 REFN ISSN 1046-5928 REMARK 1 DOI 10.1006/PREP.2000.1283 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GA3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1000012422. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.1 REMARK 210 IONIC STRENGTH : 50MM NACL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N] IL REMARK 210 -13, 25 MM PHOSPHATE BUFFER, 50 REMARK 210 MM SODIUM CHLORIDE, 1 MM EDTA, REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY; HNCACB; REMARK 210 CACBCONH; 4D CC-NOESY; 4D CN- REMARK 210 NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, ANSIG, CNS, ARIA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: USING 3D AND 4D NMR. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 3 -171.18 -54.20 REMARK 500 1 GLN A 24 179.25 -53.30 REMARK 500 1 PRO A 27 -167.95 -78.46 REMARK 500 1 CYS A 29 -82.59 68.44 REMARK 500 1 ASN A 30 28.07 -147.34 REMARK 500 1 SER A 36 148.87 -38.88 REMARK 500 1 ASN A 38 55.55 -113.87 REMARK 500 1 LEU A 39 -19.87 -43.76 REMARK 500 1 ALA A 41 -85.93 -151.61 REMARK 500 1 CYS A 57 -68.53 -135.56 REMARK 500 1 GLU A 61 -37.56 -35.62 REMARK 500 1 CYS A 71 106.70 -46.01 REMARK 500 1 HIS A 73 -165.77 170.39 REMARK 500 1 SER A 76 -136.40 -115.11 REMARK 500 1 GLN A 79 47.90 -168.02 REMARK 500 1 SER A 81 30.51 -147.74 REMARK 500 1 ASP A 87 -83.10 -144.95 REMARK 500 1 LEU A 101 -70.51 -56.84 REMARK 500 1 ARG A 111 42.21 -108.92 REMARK 500 2 VAL A 4 134.49 62.17 REMARK 500 2 GLN A 24 171.94 -54.08 REMARK 500 2 CYS A 29 -78.92 64.92 REMARK 500 2 ASN A 30 31.12 -150.26 REMARK 500 2 SER A 36 146.34 -39.26 REMARK 500 2 ASN A 38 50.63 -118.44 REMARK 500 2 LEU A 39 -31.38 -35.26 REMARK 500 2 CYS A 57 -73.27 -135.08 REMARK 500 2 CYS A 71 106.38 -46.56 REMARK 500 2 HIS A 73 -171.26 167.71 REMARK 500 2 VAL A 75 98.12 -166.48 REMARK 500 2 SER A 76 -135.62 -105.17 REMARK 500 2 SER A 81 -175.25 -59.15 REMARK 500 2 HIS A 84 37.68 -176.74 REMARK 500 2 VAL A 85 67.78 -166.22 REMARK 500 2 ASP A 87 -80.59 -123.58 REMARK 500 2 ARG A 111 48.07 23.45 REMARK 500 3 GLN A 24 179.46 -57.25 REMARK 500 3 ALA A 26 152.33 -47.67 REMARK 500 3 SER A 32 108.32 -164.73 REMARK 500 3 SER A 36 173.49 70.46 REMARK 500 3 ASN A 38 73.88 -117.62 REMARK 500 3 THR A 40 -53.99 -165.29 REMARK 500 3 CYS A 57 -75.27 -139.70 REMARK 500 3 SER A 58 -50.00 75.23 REMARK 500 3 PRO A 72 49.27 -82.43 REMARK 500 3 HIS A 73 -162.99 177.49 REMARK 500 3 SER A 76 -136.16 -115.40 REMARK 500 3 SER A 81 126.35 -176.31 REMARK 500 3 SER A 82 -78.57 -59.67 REMARK 500 3 VAL A 85 96.61 -168.60 REMARK 500 REMARK 500 THIS ENTRY HAS 383 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4843 RELATED DB: BMRB REMARK 900 NMR STRUCTURE OF INTERLEUKIN-13 DBREF 1GA3 A 2 113 UNP P35225 IL13_HUMAN 35 146 SEQADV 1GA3 GLY A 1 UNP P35225 EXPRESSION TAG SEQRES 1 A 113 GLY GLY PRO VAL PRO PRO SER THR ALA LEU ARG GLU LEU SEQRES 2 A 113 ILE GLU GLU LEU VAL ASN ILE THR GLN ASN GLN LYS ALA SEQRES 3 A 113 PRO LEU CYS ASN GLY SER MET VAL TRP SER ILE ASN LEU SEQRES 4 A 113 THR ALA GLY MET TYR CYS ALA ALA LEU GLU SER LEU ILE SEQRES 5 A 113 ASN VAL SER GLY CYS SER ALA ILE GLU LYS THR GLN ARG SEQRES 6 A 113 MET LEU SER GLY PHE CYS PRO HIS LYS VAL SER ALA GLY SEQRES 7 A 113 GLN PHE SER SER LEU HIS VAL ARG ASP THR LYS ILE GLU SEQRES 8 A 113 VAL ALA GLN PHE VAL LYS ASP LEU LEU LEU HIS LEU LYS SEQRES 9 A 113 LYS LEU PHE ARG GLU GLY ARG PHE ASN HELIX 1 AA1 SER A 7 GLN A 22 1 16 HELIX 2 AA2 MET A 43 ILE A 52 1 10 HELIX 3 AA3 ILE A 60 GLY A 69 1 10 HELIX 4 AA4 GLU A 91 GLY A 110 1 20 SHEET 1 AA1 2 VAL A 34 TRP A 35 0 SHEET 2 AA1 2 LYS A 89 ILE A 90 -1 O ILE A 90 N VAL A 34 SSBOND 1 CYS A 29 CYS A 57 1555 1555 2.03 SSBOND 2 CYS A 45 CYS A 71 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 160 0 0 4 2 0 0 6 0 0 0 9 END